{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Aframomum melegueta", "osteoporosis", "paradol"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28869564", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "05"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "09", "Day": "04"}], "Language": ["eng"], "ELocationID": ["1467", "10.3390/molecules22091467"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "9", "PubDate": {"Year": "2017", "Month": "Sep", "Day": "04"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Phenolics Isolated from Aframomum meleguta Enhance Proliferation and Ossification Markers in Bone Cells.", "Abstract": {"AbstractText": ["Osteoporosis is a serious health problem characterized by decreased bone mineral density and deterioration of bone microarchitecture. Current antiosteoporotic agents exhibit a wide range of adverse effects; meanwhile, phytochemicals are effective and safer alternatives. In the current work, nine compounds belonging to hydroxyphenylalkane and diarylheptanoid groups were isolated from <i>Aframomum meleguea</i> seeds and identified as 6-gingerol (<b>1</b>), 6-paradol (<b>2</b>), 8-dehydrogingerdione (<b>3</b>), 8-gingerol (<b>4</b>), dihydro-6-paradol (<b>5</b>), dihydrogingerenone A (<b>6</b>), dihydrogingerenone C (<b>7</b>), 1,7-bis(3,4-dihydroxy-5-methoxyphenyl)heptane-3,5-diyl diacetate (<b>8</b>), and 1-(3,4-dihydroxy-5-methoxyphenyl)-7-(3,4-dihydroxyphenyl)heptane-3,5-diyl diacetate (<b>9</b>). The structures of isolated compounds were established by NMR and mass spectral data, in addition to referring to literature data. Exposure of MCF-7, MG-63, and SAOS-2 cells to subcytotoxic concentrations of the compounds under investigation resulted in accelerated proliferation. Among them, paradol was selected for further detailed biochemical analysis in SAOS-2 cells. DNA flowcytometric analysis of cell cycle distribution revealed that paradol did not induce any significant change in the proliferation index of SAOS-2 cells. Assessment of osteogenic gene expression revealed that paradol enhanced the expression of osteocyte and osteoblast-related genes and inhibited osteoclast and RUNX suppressor genes. Biochemically, paradol enhanced alkaline phosphatase activity and vitamin D content and decreased the osteoporotic marker acid phosphatase. In conclusion, paradol, which is a major constituents of <i>A. melegueta</i> seeds, exhibited potent proliferative and ossification characteristics in bone cells."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Unit, Deanship of Scientific Research, King Abdulaziz University, Jeddah 80230, Saudi Arabia. aaabdulalrahman1@kau.edu.sa."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia. aaabdulalrahman1@kau.edu.sa."}], "LastName": "Abdel-Naim", "ForeName": "Ashraf B", "Initials": "AB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21523, Saudi Arabia. abdullah.elghamdi@gmail.com."}], "LastName": "Alghamdi", "ForeName": "Abdullah A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Unit, Deanship of Scientific Research, King Abdulaziz University, Jeddah 80230, Saudi Arabia. malgandaby@yahoo.com."}, {"Identifier": [], "Affiliation": "Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21523, Saudi Arabia. malgandaby@yahoo.com."}], "LastName": "Algandaby", "ForeName": "Mardi M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Unit, Deanship of Scientific Research, King Abdulaziz University, Jeddah 80230, Saudi Arabia. alabassif@hotmail.com."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21523, Saudi Arabia. alabassif@hotmail.com."}], "LastName": "Al-Abbasi", "ForeName": "Fahad A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia. ahmedmalabd@pharma.asu.edu.eg."}, {"Identifier": [], "Affiliation": "Pharmacology Department, Medical Division, National Research Centre, Giza 12622, Egypt. ahmedmalabd@pharma.asu.edu.eg."}], "LastName": "Al-Abd", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia. hmafifi2013@gmail.com."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. hmafifi2013@gmail.com."}], "LastName": "Abdallah", "ForeName": "Hossam M", "Initials": "HM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. ahalawany2003@yahoo.com."}], "LastName": "El-Halawany", "ForeName": "Ali M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan. cre421@yahoo.co.jp."}], "LastName": "Hattori", "ForeName": "Masao", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["cytology", "metabolism"], "DescriptorName": "Bone and Bones"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Gene Expression"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "Osteoblasts"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "Osteoclasts"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "Osteocytes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Osteogenesis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Osteoporosis"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Phenols"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seeds"}, {"QualifierName": ["chemistry"], "DescriptorName": "Zingiberaceae"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Reginster J.-Y., Burlet N. Osteoporosis: A still increasing prevalence. Bone. 2006;38:4\u20139. doi: 10.1016/j.bone.2005.11.024.", "ArticleIdList": ["10.1016/j.bone.2005.11.024", "16455317"]}, {"Citation": "Sornay-Rendu E., Munoz F., Garnero P., Duboeuf F., Delmas P.D. Identification of osteopenic women at high risk of fracture: The OFELY study. J. Bone Miner. Res. 2005;20:1813\u20131819. doi: 10.1359/JBMR.050609.", "ArticleIdList": ["10.1359/JBMR.050609", "16160738"]}, {"Citation": "Martin R.M., Correa P.H.S. Bone quality and osteoporosis therapy. Arq. Bras. Endocrinol. Metabol. 2010;54:186\u2013199. doi: 10.1590/S0004-27302010000200015.", "ArticleIdList": ["10.1590/S0004-27302010000200015", "20485908"]}, {"Citation": "Randell A., Sambrook P.N., Nguyen T.V., Lapsley H., Jones G., Kelly P.J., Eisman J.A. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos. Int. 1995;5:427\u2013432. doi: 10.1007/BF01626603.", "ArticleIdList": ["10.1007/BF01626603", "8695963"]}, {"Citation": "Lo S.S.T. Bone health status of postmenopausal Chinese women. Hong Kong Med. J. 2015;21:536\u2013541.", "ArticleIdList": ["26492837"]}, {"Citation": "Lufkin E.G., Sarkar S., Kulkarni P.M., Ciaccia A.V., Siddhanti S., Stock J., Plouffe L. Antiresorptive treatment of postmenopausal osteoporosis: Review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial. Curr. Med. Res. Opin. 2004;20:351\u2013357. doi: 10.1185/030079904125003071.", "ArticleIdList": ["10.1185/030079904125003071", "15025844"]}, {"Citation": "Brass L.M. Estrogens and Stroke: Use of Oral Contraceptives and postmenopausal use of estrogen: Current recommendations. Curr. Treat. Opt. Neurol. 2004;6:459\u2013467. doi: 10.1007/s11940-004-0004-9.", "ArticleIdList": ["10.1007/s11940-004-0004-9", "15461924"]}, {"Citation": "Strampel W., Emkey R., Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf. 2007;30:755\u2013763. doi: 10.2165/00002018-200730090-00003.", "ArticleIdList": ["10.2165/00002018-200730090-00003", "17722968"]}, {"Citation": "Yardley D.A., Yardley D. Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer. Breast Cancer. 2016;8:73\u201382.", "ArticleIdList": ["PMC4861000", "27217795"]}, {"Citation": "Dean M., Murphy B.T., Burdette J.E. Phytosteroids beyond estrogens: Regulators of reproductive and endocrine function in natural products. Mol. Cell. Endocrinol. 2017;442:98\u2013105. doi: 10.1016/j.mce.2016.12.013.", "ArticleIdList": ["10.1016/j.mce.2016.12.013", "PMC5276729", "27986590"]}, {"Citation": "Banu J., Varela E., Fernandes G. Alternative therapies for the prevention and treatment of osteoporosis. Nutr. Rev. 2012;70:22\u201340. doi: 10.1111/j.1753-4887.2011.00451.x.", "ArticleIdList": ["10.1111/j.1753-4887.2011.00451.x", "22221214"]}, {"Citation": "Bharti A.C., Takada Y., Aggarwal B.B. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 2004;172:5940\u20135947. doi: 10.4049/jimmunol.172.10.5940.", "ArticleIdList": ["10.4049/jimmunol.172.10.5940", "15128775"]}, {"Citation": "Yang M.-W., Wang T.-H., Yan P.-P., Chu L.-W., Yu J., Gao Z.-D., Li Y.-Z., Guo B.-L. Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine. 2011;18:205\u2013213. doi: 10.1016/j.phymed.2010.05.011.", "ArticleIdList": ["10.1016/j.phymed.2010.05.011", "20637579"]}, {"Citation": "Wilkinson J.M. Effect of ginger tea on the fetal development of Sprague-Dawley rats. Reprod. Toxicol. 2000;14:507\u2013512. doi: 10.1016/S0890-6238(00)00106-4.", "ArticleIdList": ["10.1016/S0890-6238(00)00106-4", "11099876"]}, {"Citation": "Ito S., Ohmi A., Sakamiya A., Yano T., Okumura K., Nishimura N., Kagontani K. Ginger hexane extract suppresses RANKL-induced osteoclast differentiation. Biosci. Biotechnol. Biochem. 2016;80:779\u2013785. doi: 10.1080/09168451.2015.1127133.", "ArticleIdList": ["10.1080/09168451.2015.1127133", "26967638"]}, {"Citation": "Fan J.Z., Yang X., Bi Z.G. The effects of 6-gingerol on proliferation, differentiation, and maturation of osteoblast-like MG-63 cells. Braz. J. Med. Biol. Res. 2015;48:637\u2013643. doi: 10.1590/1414-431X20154494.", "ArticleIdList": ["10.1590/1414-431X20154494", "PMC4512103", "25923459"]}, {"Citation": "Iwu M. In: Handbook of African Medicinal Plants. 2nd ed. Iwu M., editor. CRC Press, Taylor and Francis Group; New York, NY, USA: 2014."}, {"Citation": "El-Halawany A.M., El Dine R.S., Chung M.H., Nishihara T., Hattori M. Screening for estrogenic and antiestrogenic activities of plants growing in Egypt and Thailand. Pharmacogn. Res. 2011;3:107\u2013113.", "ArticleIdList": ["PMC3129019", "21772754"]}, {"Citation": "Mohammed A., Koorbanally N.A., Islam M.S. Phytochemistry, antioxidant activity and inhibition of key enzymes linked to type 2 diabetes by various parts of Aframomum melegueta in vitro. Acta Pol. Pharm. 2016;73:403\u2013417.", "ArticleIdList": ["27180433"]}, {"Citation": "Adefegha S.A., Olasehinde T.A., Oboh G. Essential oil composition, antioxidant, antidiabetic and antihypertensive properties of two Afromomum species. J. Oleo Sci. 2017;66:51\u201363. doi: 10.5650/jos.ess16029.", "ArticleIdList": ["10.5650/jos.ess16029", "27928138"]}, {"Citation": "Ogbole O.O., Ajaiyeoba E.O. Traditional management of tuberculosis in Ogun State of Nigeria: The practice and ethnobotanical survey. Afr. J. Tradit. Complement. Altern. Med. 2009;7:79\u201384. doi: 10.4314/ajtcam.v7i1.57270.", "ArticleIdList": ["10.4314/ajtcam.v7i1.57270", "PMC3005385", "21304616"]}, {"Citation": "Gbolade A. Ethnobotanical study of plants used in treating hypertension in Edo State of Nigeria. J. Ethnopharmacol. 2012;144:1\u201310. doi: 10.1016/j.jep.2012.07.018.", "ArticleIdList": ["10.1016/j.jep.2012.07.018", "22975417"]}, {"Citation": "Ma S., Zhang S., Duan W., Wang W. An enantioselective synthesis of (+)-(S)-[n]-gingerols via the l-proline-catalyzed aldol reaction. Bioorg. Med. Chem. Lett. 2009;19:3909\u20133911. doi: 10.1016/j.bmcl.2009.03.081.", "ArticleIdList": ["10.1016/j.bmcl.2009.03.081", "19362472"]}, {"Citation": "Jiang H., Timmermann B.N., Gang D.R. Characterization and identification of diarylheptanoids in ginger (Zingiber officinale Rosc.) using high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2007;1:509\u2013518. doi: 10.1002/rcm.2858.", "ArticleIdList": ["10.1002/rcm.2858", "17238228"]}, {"Citation": "El-Halawany A.M., El Dine R.S., El Sayed N.S., Hattori M. Protective effect of Aframomum melegueta phenolics against CCl4-induced rat hepatocytes damage; role of Apoptosis and pro-inflammatory cytokines inhibition. Sci. Rep. 2014;4:5880. doi: 10.1038/srep05880.", "ArticleIdList": ["10.1038/srep05880", "PMC5376205", "25077538"]}, {"Citation": "Tackie A., Dwuma-Badu D., Ayim J., Dabra T., Knapp J., Slatkin D., Schiff P.L., Jr. Hydroxyphenylalkanones from Amomum melegueta. Phytochemistry. 1975;14:853\u2013854. doi: 10.1016/0031-9422(75)83070-6.", "ArticleIdList": ["10.1016/0031-9422(75)83070-6"]}, {"Citation": "El-Halawany A.M., Hattori M. Anti-oestrogenic diarylheptanoids from Aframomum melegueta with in silico oestrogen receptor alpha binding conformation similar to enterodiol and enterolactone. Food Chem. 2012;134:219\u2013226. doi: 10.1016/j.foodchem.2012.02.100.", "ArticleIdList": ["10.1016/j.foodchem.2012.02.100"]}, {"Citation": "Kling J.M., Clarke B.L., Sandhu N.P. Osteoporosis prevention, screening, and treatment: A review. J. Women\u2019s Heal. 2014;23:563\u2013572. doi: 10.1089/jwh.2013.4611.", "ArticleIdList": ["10.1089/jwh.2013.4611", "PMC4089021", "24766381"]}, {"Citation": "Papapetrou P.D. Bisphosphonate-associated adverse events. Hormones (Athens) 2009;8:96\u2013110. doi: 10.14310/horm.2002.1226.", "ArticleIdList": ["10.14310/horm.2002.1226", "19570737"]}, {"Citation": "Sharan K., Siddiqui J.A., Swarnkar G., Maurya R., Chattopadhyay N. Role of phytochemicals in the prevention of menopausal bone loss: Evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies. Curr. Med. Chem. 2009;16:1138\u20131157. doi: 10.2174/092986709787581806.", "ArticleIdList": ["10.2174/092986709787581806", "19275617"]}, {"Citation": "Mosli H.A., Tolba M.F., Al-Abd A.M., Abdel-Naim A.B. Catechol estrogens induce proliferation and malignant transformation in prostate epithelial cells. Toxicol. Lett. 2013;220:247\u2013258. doi: 10.1016/j.toxlet.2013.05.002.", "ArticleIdList": ["10.1016/j.toxlet.2013.05.002", "23685341"]}, {"Citation": "Soto A.M., Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7) J. Steroid Biochem. 1985;23:87\u201394. doi: 10.1016/0022-4731(85)90265-1.", "ArticleIdList": ["10.1016/0022-4731(85)90265-1", "4021494"]}, {"Citation": "Weng C.-J., Wu C.-F., Huang H.-W., Ho C.-T., Yen G.-C. Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol. Nutr. Food Res. 2010;54:1618\u20131627. doi: 10.1002/mnfr.201000108.", "ArticleIdList": ["10.1002/mnfr.201000108", "20521273"]}, {"Citation": "Shukla Y., Singh M. Cancer preventive properties of ginger: A brief review. Food Chem. Toxicol. 2007;45:683\u2013690. doi: 10.1016/j.fct.2006.11.002.", "ArticleIdList": ["10.1016/j.fct.2006.11.002", "17175086"]}, {"Citation": "Mitchison J.M., Carter B.L. Cell cycle analysis. Methods Cell Biol. 1975;11:201\u2013219.", "ArticleIdList": ["52822"]}, {"Citation": "Takahashi M. Theoretical basis for cell cycle analysis: II. Further studies on labelled mitosis wave method. J. Theor. Biol. 1968;18:195\u2013209. doi: 10.1016/0022-5193(68)90161-6.", "ArticleIdList": ["10.1016/0022-5193(68)90161-6", "5647131"]}, {"Citation": "Kanis J.A., Gl\u00fcer C.C. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos. Int. 2000;11:192\u2013202. doi: 10.1007/s001980050281.", "ArticleIdList": ["10.1007/s001980050281", "10824234"]}, {"Citation": "Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: Now and the future. Lancet. 2011;377:1276\u20131287. doi: 10.1016/S0140-6736(10)62349-5.", "ArticleIdList": ["10.1016/S0140-6736(10)62349-5", "PMC3555696", "21450337"]}, {"Citation": "Schaffler M.B., Kennedy O.D. Osteocyte signaling in bone. Curr. Osteoporos. Rep. 2012;10:118\u2013125. doi: 10.1007/s11914-012-0105-4.", "ArticleIdList": ["10.1007/s11914-012-0105-4", "PMC3366431", "22552701"]}, {"Citation": "Parisuthiman D., Mochida Y., Duarte W.R., Yamauchi M. Biglycan modulates osteoblast differentiation and matrix mineralization. J. Bone Miner. Res. 2005;20:1878\u20131886. doi: 10.1359/JBMR.050612.", "ArticleIdList": ["10.1359/JBMR.050612", "16160746"]}, {"Citation": "Sapir-Koren R., Livshits G. Osteocyte control of bone remodeling: Is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos. Int. 2014;25:2685\u20132700. doi: 10.1007/s00198-014-2808-0.", "ArticleIdList": ["10.1007/s00198-014-2808-0", "25030653"]}, {"Citation": "Dayong Guo D., Bonewald L.F. Advancing our understanding of osteocyte cell biology. Ther. Adv. Musculoskelet. Dis. 2009;1:87\u201396. doi: 10.1177/1759720X09341484.", "ArticleIdList": ["10.1177/1759720X09341484", "PMC3383482", "22870430"]}, {"Citation": "Li X., Ominsky M.S., Niu Q.-T., Sun N., Daugherty B., D\u2019Agostin D., Kurahara C., Gao Y., Cao J., Gong J., et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J. Bone Miner. Res. 2008;23:860\u2013869. doi: 10.1359/jbmr.080216.", "ArticleIdList": ["10.1359/jbmr.080216", "18269310"]}, {"Citation": "Komori T. Roles of Runx2 in skeletal development. Adv. Exp. Med. Biol. 2017;962:83\u201393.", "ArticleIdList": ["28299652"]}, {"Citation": "Abdallah H.M., Al-Abd A.M., Asaad G.F., Abdel-Naim A.B., El-halawany A.M. Isolation of antiosteoporotic compounds from seeds of Sophora japonica. PLoS ONE. 2014;9:e98559. doi: 10.1371/journal.pone.0098559.", "ArticleIdList": ["10.1371/journal.pone.0098559", "PMC4043785", "24892557"]}, {"Citation": "Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990;82:1107\u20131112. doi: 10.1093/jnci/82.13.1107.", "ArticleIdList": ["10.1093/jnci/82.13.1107", "2359136"]}, {"Citation": "Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034.", "ArticleIdList": ["10.1186/gb-2002-3-7-research0034", "PMC126239", "12184808"]}, {"Citation": "Gerhardt W., Nielsen M.L., Nielsen O.V., Olsen J.S., Statland B.E. Clinical evaluation of routine measurement of liver and bone alkaline phosphatases in human serum. Differential inhibition by l-phenylalanine and carbamide (urea) on the LKB 8600 reaction rate analyzer. Clin. Chim. Acta. 1974;53:291\u2013297. doi: 10.1016/0009-8981(74)90267-8.", "ArticleIdList": ["10.1016/0009-8981(74)90267-8", "4847104"]}, {"Citation": "Fu J.Y., Muller D. Simple, rapid enzyme-linked immunosorbent assay (ELISA) for the determination of rat osteocalcin. Calcif. Tissue Int. 1999;64:229\u2013233. doi: 10.1007/s002239900608.", "ArticleIdList": ["10.1007/s002239900608", "10024381"]}]}], "History": [{"Year": "2017", "Month": "8", "Day": "13"}, {"Year": "2017", "Month": "8", "Day": "30"}, {"Year": "2017", "Month": "9", "Day": "2"}, {"Year": "2017", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["28869564", "PMC6151453", "10.3390/molecules22091467", "molecules22091467"]}}]}